|
Physicians and Scholars Cooperation Group
AT: University of Connecticut, Dept. Molecular & Cell Biology,
BSP 305 91 North Eagleville Road, Unit 3125,
Storrs,
Connecticut 06269-3125 U.S.A.
TEL: (860) 816-6963; FAX: (860) 486-4331
Email: david.haines@uconn.edu
INFLAMMATORY DISEASE IN CHEMICAL VICTIMS
A MODEL FOR HEALTHCARE WORLDWIDE:
Conflicts in the Middle East 1980-1991 exposed residents of 3 nations: Iran, Iraq and Kuwait, to a diverse spectrum of highly toxic materials, including chemical weapons, partly combusted raw petroleum and many other toxicants that can cause acute injury and/or chronic disease over many decades.
This horrific tragedy prompted at least some modest international cooperation that resulted in SPG member Dr. David Haines organizing PSCG. Washington Post, June 2006: Reaching Out to Iran. Research on Gas Victims May Offer a Bridge. By David Ignatius. » Washington Post: Reaching Out to Iran
PSCG developed a general approach to prevention of and therapy for inflammatory pathology and disease associated with chemical exposures. The PSCG mission and ImmuneACCORD™ model for healthcare delivery allowed Summative Synergy Product Groups (SPG) and PSCG efforts to dovetail towards helping chemical victims and achieving healthcare worldwide.
The PSCG Mission:
Define scope of problem.
Identify major trends in health status of chemical exposed and normal populations. Use this data to help predict public health burden and national healthcare priorities in Iraq, Iran and Kuwait.
Define health problems.
Perform immunological and molecular biological studies of disease.
Develop novel therapeutic strategies.
Treatments must be low-cost and non-toxic and can include public health, dietary phytonutrition and phytotherapy and other pharmaceutical elements.
Design healthcare delivery worldwide.
Healthcare delivery must target local medical problems and be sustainable within the resource and constraints of each nation.
|